Autologous Platelet Rich Plasma and Progenitor Stem Cell Biologics has become a standard of care in modern medicine.  With 20 + years of innovation and development, EmCyte Corporation® is widely recognized as the standard bearer, with a product portfolio that meets the highest achievable performance outcomes in point of care regenerative medicine.  EmCyte biologics has been successfully used in <2 million patients, making it the most widely used single platform in the world.  Join the family of clinical effectiveness and appreciable outcomes with EmCyte Autologous Regenerative Biologics.

Emcyte PurePRP® – Platelet Rich Plasma

EmCyte has remained committed to innovation that truly makes a clinical difference. Emcyte’s highly versatile platform offers providers a choice of treatment types using the following devices:

• 20ml, 30ml, 60ml & 120ml PRP options
• Leukocyte/Neutrophil Poor
• Leukocyte/Neutrophil Rich

To learn which options are best for your practice, contact me for a consult.

Emcyte A2M – Alpha-2-Macroglobulin

Alpha-2-macroglobulin (A2M) is found in our plasma. This molecule is a powerful inhibitor of cartilage catabolic factors that slow cartilage breakdown and prevent cartilage loss.

A2M signals the destructive cells to stop their degenerative effect. This inhibiting factor makes A2M a viable option for biologic treatments, promoting increased strength and improving overall function over a 4-6 week period.

Emcyte Progenikine® Adipose Concentrating System

The Progenikine® adipose concentrating system is a powerful, FDA-cleared device that offers a clean adipose concentrate sample devoid of oil and tumescent infranatant.

• 25ml and 50ml concentrating kits
• 4-Minute centrifuge spin
• Isolates highest concentration of regenerative cells

Emcyte Pure BMC® – Bone Marrow Concentrate

Designed to improve performance outcomes, PureBMC® allows physicians to more accurately collect high therapeutic cell concentrates with low red blood cell content. Hematopoietic stem cells (CD34+), total nucleated cell (TNC), mesenchymal stem cell (CFU-F) and platelet isolation is perfected in the PureBMC® system.

Using a specialized cell isolation technique, PureBMC® provides more than 9X cell concentration in 7ml of PureBMC®. Preparation times are less than 10 minutes at the point of care. With careful attention to the details of gradient cell isolation, PureBMC® is a viable choice for a low hematocrit and high yielding bone marrow cell concentrate product.